- Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System
- Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
- Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
- Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
Key statistics
On Friday, Quince Therapeutics Inc (QNCX:NSQ) closed at 0.71, 9.15% above its 52-week low of 0.6505, set on Jun 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.70 |
---|---|
High | 0.72 |
Low | 0.6979 |
Bid | 0.6703 |
Offer | 0.71 |
Previous close | 0.6979 |
Average volume | 159.74k |
---|---|
Shares outstanding | 43.22m |
Free float | 37.51m |
P/E (TTM) | -- |
Market cap | 30.68m USD |
EPS (TTM) | -0.7599 USD |
Data delayed at least 15 minutes, as of Jun 14 2024 21:00 BST.
More ▼